vTv Therapeutics Inc (NASDAQ:VTVT)
| 1.72 Delayed Data As of 3:59pm ET |  -0.07 / -3.91%Today’s Change | 1.44 Today|||52-Week Range 4.75 | -7.53% Year-to-Date |
Latest VTVT News | Press Releases
| RedHill (RDHL) Down on Unsatisfactory Data From COVID-19 Study Sep 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.79 |
| Today’s open | 1.80 |
| Day’s range | 1.71 - 1.80 |
| Volume | 29,826 |
| Average volume (3 months) | 1,165,839 |
| Market cap | $173.2M |
Data as of 3:59pm ET, 09/20/2021
Growth & Valuation
| Earnings growth (last year) | +69.51% |
| Earnings growth (this year) | -32.35% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +132.05% |
| P/E ratio | NM |
| Price/Sales | 13.67 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Kirin Group Holdings... | -0.02 | -5.66% |
| --Top Form Internation... | +0.01 | +1.79% |
| --Union Asia Enterpris... | 0.00 | 0.00% |
| ---- |
Data as of 09/20/2021
Financials
| Next reporting date | November 3, 2021 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $6.4M |
| Annual profit (last year) | -$8.5M |
| Net profit margin | -132.51% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters High Point, North Carolina |
Forecasts
